Clinical Trial Opportunity for Triple-Negative Breast Cancer
| Date | Form | Description | XBRL | Pages |
|---|---|---|---|---|
| 01/28/21 | UPLOAD | Form UPLOAD: SEC-generated letter | 1 | |
| 01/27/21 | 8-K | Form 8-K: Current report filing | 4 | |
| 01/21/21 | S-3 | Form S-3: Registration statement for specified transactions by certain issuers | 19 | |
| 01/19/21 | DEF 14A | Form DEF 14A: Definitive proxy statements | 8 | |
| 01/12/21 | 8-K | Form 8-K: Current report filing | 4 | |
| 01/08/21 | PRE 14A | Form PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition | 6 | |
| 01/08/21 | D | Form D: Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. | 6 | |
| 12/28/20 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 2 | |
| 12/28/20 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 2 | |
| 12/28/20 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 2 |